What is Sidekick Health?
Sidekick Health operates a patient-centric digital care platform designed to prevent and manage chronic illnesses. Founded by medical doctors frustrated with the limitations of traditional treatment for lifestyle-related diseases, the company leverages an evidence-based clinical approach combined with behavioral economics and gamification. Its platform, CE-marked as a Class I Medical Device, is scalable to over 40 chronic diseases and has demonstrated clinically proven positive impacts on health outcomes, including weight management, blood glucose control, and medication adherence. The company's technology has also been adapted for remote patient monitoring, including support for COVID-19 patients.
How much funding has Sidekick Health raised?
Sidekick Health has raised a total of $80M across 3 funding rounds:
Angel/Seed
$5M
Series A
$20M
Series B
$55M
Angel/Seed (2018): $5M with participation from Novator Partners
Series A (2020): $20M led by Novator Partners, Wellington Partners, Frumtak Ventures, and Asabys Partners Company
Series B (2022): $55M supported by Novator Ventures, Wellington Partners, Asabys Partners, and Frumtak Ventures
Key Investors in Sidekick Health
Novator Partners
Novator Partners is an international private equity and growth equity investor with expertise in health and technology sectors, focusing on supporting companies with strategic growth and value creation.
Wellington Partners
Wellington Partners is a leading European venture capital firm specializing in early- and growth-stage life science companies, including digital health, aiming to transform innovative ideas into successful businesses.
Frumtak Ventures
Frumtak Ventures is an Icelandic early-stage venture capital fund that invests in local innovation with global potential, supporting founders with strategic partnerships and funding for scaling.
What's next for Sidekick Health?
The recent Series B financing, characterized as a major strategic investment, positions Sidekick Health for significant expansion and market penetration. This capital infusion is expected to fuel the scaling of its digital care platform across more chronic conditions and geographies. The company's focus on clinical validation and patient outcomes, coupled with its robust technology, suggests a strategic direction towards solidifying its market leadership in digital health solutions for chronic disease management and potentially exploring new therapeutic areas or partnerships.
See full Sidekick Health company page
